We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

A FTSE 250 share and an ETF to consider for an ISA!

Targeting London’s FTSE 250 index could be a shrewd idea as risk appetite improves. Here a top stock to consider alongside a surging ETF.

| More on:

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Looking for stocks to buy in a tax-efficient Stocks and Shares ISA? Here’s a top FTSE 250 share and a popular exchange-traded fund (ETF) I think demand a close look.

Please note that tax treatment depends on the individual circumstances of each client and may be subject to change in future. The content in this article is provided for information purposes only. It is not intended to be, neither does it constitute, any form of tax advice. Readers are responsible for carrying out their own due diligence and for obtaining professional advice before making any investment decisions.

Should you buy Target Healthcare REIT Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

iShares Physical Gold ETF — playing gold’s bull run

Gold’ may have lost some of its lustre in recent hours, pulling funds like iShares Physical Gold ETF (LSE:SGLN) lower. Demand for the safe-haven asset has dipped as news of a US-China trade deal’s boosted demand for riskier ones.

There may be further volatility in the days and weeks ahead, and particularly as investors seek to book profits. But I believe bullion’s multi-year bull run is far from over, meaning gold ETFs remain attractive assets in my book.

There’s a blend of factors that suggest gold may hit new records above current peaks around $3,500 an ounce. Mounting geopolitical tensions, and lasting uncertainty over US economic and foreign policy. A raft of further interest rate cuts will also support the inflation-hedging precious metal, along with possible further falls in the US dollar.

Strong central bank buying should also keep fuelling gold’s price boom. Institutions bought 244 tonnes of the metal in quarter one, prompting the World Gold Council (WGC) to predict “another strong year of buying.”

ETFs like this are more convenient ways for retail investors to trade gold than buying physical gold. And this particular iShares one has one of the lowest expense ratios on the market (at 0.12%).

Target Healthcare REIT — a FTSE 250 dividend machine

Real estate investment trust (or REIT) Target Healthcare (LSE:THRL) has risen sharply in recent months, driven by hopes of a sustained fall in interest rates. But to my mind it still looks dirt cheap.

At 99.5p per share, the FTSE 250 business — which operates 94 care homes across the UK — trades a whopping 14% discount to its net asset value (NAV) per share.

It also packs a vast 6% forward dividend yield. This reflects in part REIT rules, which state at least 90% of profits from rental operations must be distributed in the form of dividends.

Target could be one of the most secure passive income stocks to own today, in my opinion. Not only does it operate in a highly defensive sector. With 34 tenants on its books, it has the depth to absorb any individual setbacks that could impact earnings and dividends.

Furthermore, its tenants are sealed into on ultra-long-term contracts, providing excellent long-term profits visibility (the weighted average unexpired lease term (WAULT) was 26.1 years as of December).

On the downside, new UK immigration policy poses a potential long-term problem to the care homes sector. More specifically, tighter rules could impact inflows of key healthcare workers, potentially pushing up tenants’ costs and reducing occupancy rates.

Yet on balance, I still think the trust’s outlook is extremely bright over the coming decades, underpinned by soaring care home demand as Britain’s elderly population rapidly grows.

Royston Wild has positions in Target Healthcare REIT Plc. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

photo of Union Jack flags bunting in local street party
Investing Articles

Here’s what £20,000 invested in the FTSE 100 in July 2025 is worth today…

Harvey Jones flags up just how well the FTSE 100 has done over the last year, and picks out a…

Read more »

Investing Articles

Could the BAE Systems share price really hit £26 in July 2027? Here’s what the experts say…

The BAE Systems share price stands at around £19 today but there are some really upbeat broker forecasts out there.…

Read more »

Investing Articles

£2,000 invested in penny stock Hardide at the start of 2026 is now worth…

Penny stock Hardide has generated blockbuster returns for investors in 2026. The big question is – does it have further…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Dividend Shares

Legal & General vs Investec: which is the best stock for second income?

Jon Smith talks about two of the top FTSE 100 dividend shares, ranked by yield, and weighs up which could…

Read more »

UK supporters with flag
Investing Articles

Great news for Rolls-Royce shareholders this week!

Rolls-Royce shares have jumped back above 1,400p this week. What has driven the FTSE 100 stock higher? And can it…

Read more »

Tree lined "tunnel" in the English countryside of West Sussex in autumn
Investing Articles

Here’s 1 FTSE 100 stock I’ll happily hold for decades

Identifying stocks I’d be comfortable holding for 10-20 years can be a daunting task, but the FTSE 100 has many…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

By mid-2027, analysts expect $2,913 in Micron stock to be worth

Could investing in Micron stock today be like investing in Nvidia three years ago when it was trading at significantly…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

£5,000 invested in SpaceX stock after the IPO is now worth…

To the surprise of many, SpaceX stock has fallen below its IPO price of $135 meaning that those who bought…

Read more »